HomeNRIX • NASDAQ
add
Nurix Therapeutics Inc
Previous close
$17.59
Day range
$16.32 - $17.54
Year range
$8.18 - $22.50
Market cap
1.70B USD
Avg Volume
1.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Nov 2025info | Y/Y change |
|---|---|---|
Revenue | 13.58M | 2.21% |
Operating expense | 13.65M | 27.35% |
Net income | -78.22M | -33.60% |
Net profit margin | -576.13 | -30.72% |
Earnings per share | -0.82 | -9.33% |
EBITDA | -81.58M | -28.65% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Nov 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 592.94M | -2.73% |
Total assets | 688.14M | 2.81% |
Total liabilities | 149.39M | 4.94% |
Total equity | 538.75M | — |
Shares outstanding | 102.84M | — |
Price to book | 3.33 | — |
Return on assets | -34.32% | — |
Return on capital | -40.60% | — |
Cash Flow
Net change in cash
| (USD) | Nov 2025info | Y/Y change |
|---|---|---|
Net income | -78.22M | -33.60% |
Cash from operations | -67.83M | -39.14% |
Cash from investing | 346.00K | 100.25% |
Cash from financing | 236.01M | 17.70% |
Net change in cash | 168.52M | 1,438.59% |
Free cash flow | -40.36M | -72.35% |
About
Founded
2009
Headquarters
Website
Employees
317
